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Many neurodegenerative disorders are linked to irreversible protein aggregation, a process
that usually comes along with toxicity and serious cellular damage. However, it is emerging
that protein aggregation can also serve for physiological purposes, as impressively shown
for prions. While the aggregation of this protein family was initially considered exclusively
toxic in mammalians organisms, it is now almost clear that many other proteins adopt
prion-like attributes to rationally polymerize into higher order complexes with organized
physiologic roles. This implies that cells can tolerate at least in some measure the
accumulation of inherently dangerous protein aggregates for functional profit. This review
summarizes currently known strategies that living organisms adopt to preserve beneficial
aggregation, and to prevent the catastrophic accumulation of toxic aggregates that
frequently accompany neurodegeneration.
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INTRODUCTION
Low structural complexity is at the basis of highly diversified
molecular recognition, whereby one flexible protein region
can bind to various heterogeneous ligands by conformational
adaptation. Proteins can functionally benefit from binding
promiscuity for key regulatory processes such as signal
transduction, transcription, RNA processing and translation.
Proteins situated on intersecting hubs of different pathways can
undergo multifunctional interactions, functioning as molecular
switches by means of conformational variability. However, the
benefits of conformational freedom come along with the menace
of protein misfolding and multifunctional failure. Although
each living organism invests conspicuous amounts of energy for
the rescue or elimination of misfolded polypeptides, a possible
inability of the cell to cope with misfolded polypeptides inevitably
leads to a massive functional destabilization, whereby proteins
can either lose their original function (loss-of-function), or
they acquire an improper, and therefore mostly lethal function
(gain-of-function), eventually aggregating after the complete
collapse of folding and clearance pathways.
The central nervous system (CNS) is particularly susceptible
to protein misfolding, but the reasons of such selective neuronal
vulnerability are still elusive (Saxena and Caroni, 2011). Although
healthy adult neurons can manage proteostasis by standard
folding and degradation routines (see Section Molecular catchers
Abbreviations: CNS, central nervous system; PD, Parkinson Disease; AD,
Alzheimer Disease; ALS, amyotrophic lateral sclerosis; FTD, frontotemporal
dementia; HD, Huntington Disease; aSyn, alpha-synuclein; Abeta, beta-
amyloid; prp, major prion protein; htt, huntingtin; PLR, prion-like region;
SG, stress granules; hsp, heat shock protein; UPS, ubiquitin-proteasome
system; CMA, chaperone–mediated autophagy; MA, macroautophagy; GAG,
glycosaminoglycan; HSPG, heparan suphate proteoglycans.
in the amyloid rye: heat shock proteins and proteolytic pathways),
macroscopic protein misfolding manifestations prevail with
senescence, as attested by the occurrence of ageing-associated
neurodegenerative disorders such as Parkinson Disease (PD),
Alzheimer Disease (AD), spongiphorm encephalopathies, or
amyotrophic lateral sclerosis (ALS), all of them displaying
unsoluble protein inclusions as a signature.
AMYLOID AGGREGATION
STRUCTURAL PROPERTIES OF AMYLOIDS
Irrespectively of the protein structure and the exact anatomic
localization, one type of proteinaceous inclusions appearing in the
CNS features some unifying histologic and biophysical hallmarks
classified under the term “amyloid”, consisting of (A) a fibrous,
non-branched morphology, (B) the ability to alter the spectral
properties of the dyes Congo red and thioflavin T, and (C)
X-ray diffraction patterns typical of cross-beta structure. The
term was coined by German pathologist Rudolf Virchow during
the characterization of masses in human brains described as
“corpora amylacea”. Virchow perceived the relationship between
amyloids and disease, when he addressed the problem of “amyloid
degeneration” (Virchow, 1855). Today, it is well established
that the appearance of amyloids is associated with a chronic
tissue degeneration of the brain, and although not restricted
to this organ, our current understanding of misfolding diseases
is invariably linked to amyloid-associated neurological brain
disorders (For a detailed list of known amyloid diseases, we refer
to the classification of the International Society of Amyloidosis
Sipe et al., 2014).
Amyloid aggregation is stereotypically linked to conformati-
onal flexibility, which allows for structurally diverse polypeptides
to fold from a native into an alternative structure of the same
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chemical composition, but with high beta-sheet content, a
remarkable resistance against proteolytic and denaturing agents,
and the ability to self-associate into fibers of typical cross-beta
structure (Eisenberg and Jucker, 2012). The pathway of this
association is dynamically variegated, highly perturbable, and
sensitive to a repertoire of factors such as genetic mutations,
small ligands, changes of the physico-chemical environment,
or post-translational side chain modifications (Eichner and
Radford, 2011). The resulting heterogeneous multiplicity of
conformational intermediates differing in size, shape and stability
poses an obstacle in isolating and unambiguously categorizing
amyloid aggregates, especially these conformers among them
which are believed to be proteotoxic (Eisenberg and Jucker,
2012), and which likely accumulate in low amounts somewhere
between native polypeptide and mature amyloid. Improved
biophysical techniques can in part overcome these limitations,
and they are beginning to provide useful structural insights of
amyloid folding intermediates. By combining rapid fluorescence
techniques with NMR spectroscopy, Sarkar et al. measured
conformational fluctuations of a short-lived, low-abundance AD-
associated beta-amyloid (Abeta) oligomer (Sarkar et al., 2014).
They could pinpoint the dynamic structure of this oligomer
to a patchwork of amino acid segments which fold locally
before the transition into highly ordered amyloid filaments.
Likewise, Röthlein et al. employed time resolved fluorescence
and computational calculations to obtain structural views of an
extremely unstable huntingtin (htt) amyloid filament (Röthlein
et al., 2014).
MOLECULAR PATHWAYS OF AMYLOID PROPAGATION
Amyloid folding has been coupled early to prion diseases
(Prusiner et al., 1983), a type of devastating neurodegenerative
disorders that are transmitted by direct and self-sustained
intercellular propagation of toxic agents, which constitutes an
outstanding and devastating strategy to bypass genetic routes of
infection. While the infectious prion particle known as PrPSc is
typically amyloid (Prusiner et al., 1983), the cellular conformer
PrPc is a non-amyloid, non-infectious globular protein of still
undefined function. This striking difference led to suppose
that prion proteins must access an amyloid state to acquire
transmissible properties.
A growing amount of studies suggests that this type of cell-
to-cell transmission is apparently common to amyloids, as it
has been observed also for other amyloidogenic proteins with
well-known implication in neurodegenerative diseases (Table 1),
suggesting that the amyloid fold is a structural prerequisite of
cell-to-cell propagation (Eisenberg and Jucker, 2012). Indeed,
it was discovered, that amyloidogenic proteins such as alpha-
Synunclein (aSyn), tau, or Abeta can also propagate between
cells, and that these transmissible particles share structural
properties closely similar to those of the archetypic infectious
particle PrPsc: they have a predominant beta-sheet structure,
a remarkable resistance against proteolytic and denaturing
agents, and a self-templating ability (Prusiner et al., 1983;
Luk et al., 2012; Iba et al., 2013; Sanders et al., 2014; Stöhr
et al., 2014; Watts et al., 2014). Similar rearrangements are
likely to occur for endogenous tau in mice brains upon the
stereotactic delivery of toxic tau seeds, which is sufficient to
initiate spreading of AD-like neurofibrillary tangles along a
spatially defined trajectory (Iba et al., 2013). In close analogy,
the injection of aSyn seeds into brains of healthy mice triggers
the self-perpetuating polymerization of endogenous aSyn and
the development of clinical symptoms of PD (Luk et al., 2012).
In both cases, the sequential diffusion of proteotoxicity along
interconnected brain regions substantiates the theory of a staged
evolution of PD and AD (Braak et al., 2006). With respect
to original prions, all these proteins have thus been attributed
“prion-like” or “prionoid” propagation properties. However,
complicating a pathologic interpretation is the occurrence
of different conformationally variable toxic species from the
same protein, with separate propagation behavior and distinct
phenotypic manifestations of the same condition. Sanders et al.
demonstrated that tau, the signature protein of tauopathies,
forms biochemically and morphologically distinct oligomers
accounting for different disease phenotypes, with AD inclusions
showing the most homogenous composition (Sanders et al.,
2014). Similar has been shown for Abeta, the major component
of AD amyloid plaques. Different patient-derived as well as
synthetic species of Abeta display an individual transmission
behavior, accumulation pattern, aggregate morphology, and
chemical stability (Stöhr et al., 2014; Watts et al., 2014).
Bousset et al., also reported of two differently toxic aSyn
conformers with separate propagation properties (Bousset et al.,
2013). Additional complexity rises from the ability of particular
amyloid aggregates to act as cross-nucleation seeds for other
structurally unrelated proteins. Alpha-Synunclein (aSyn), the
major constituent of PD associated Lewy Inclusions, can initiate
the deposition of tau in primary neurons and transgenic
mice (Guo et al., 2013), while TDP-43 amyloids can seed
for Abeta fibril growth (Fang et al., 2014), which might
contribute to co-morbidities observed for some types of amyloid
pathologies.
Exosomes
We have only a slight clue on the mechanisms of intercellular
prion spreading. Recent investigations point to exosomes
(Table 1), a type of membrane-enclosed vesicle sized 30–100 nm,
with the ability of transporting a remarkably diverse cargo
ranging from active proteins to different RNA particles for cellular
exchange (Kowal et al., 2014). Exosomes have been associated
with prion transmission since the isolation of PrPsc from exosome
preparations after cellular infection with sheep prions (Fevrier
et al., 2004), and PrP-loaded exosomes could be successively
isolated from brain fluids of infected animals (Vella et al.,
2008).
It seems that the exosome-mediated secretion of amyloid-
associated proteins is an organized process, as it can be
triggered by determinate signaling events, such as calcium
release (Emmanouilidou et al., 2010), or platelet activation
(Robertson et al., 2006). Of fundamental importance, PrPsc
or aSyn oligomers isolated from exosomes retain full toxicity,
suggesting that these organelles can indeed serve as infectious
vehicles (Fevrier et al., 2004; Vella et al., 2007; Danzer et al., 2012).
This leads to hypothesize that the exosome-mediated release
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Table 1 | Summary of representative proteins handled within this review, with respect to pathology, and prion/prion-like properties.
Protein Most relevant Amyloid Cell-to-cell Exosomal HSPG
name associated diseases polymerization transmission secretion binding
aSyn PD; Yesa Yes (Luk et al., 2012) Yes (Alvarez-
Erviti et al.,
2011)
Yes (Holmes et al.,
2013)Dementia with Lewy
Bodies
Abeta AD Yesa Yes (Stöhr et al.,
2014; Watts et al.,
2014)
Yes (Rajendran
et al., 2006)
Yes (Holmes et al.,
2013)
PrP spongiphorm
encephalopathies
Yesa Yesa Yes (Fevrier et al.,
2004)
Yes (Horonchik et al.,
2005)
tau tauopathies Yesb (Iba et al., 2013;
Morozova et al., 2013)
Yes (Iba et al., 2013) Yes (Saman
et al., 2012)
Yes (Holmes et al.,
2013)
FUS ALS; FTD Yes (Schwartz et al.,
2013 (in the presence
of RNA); Nomura et al.,
2014 (G156E variant);
Han et al., 2012; Kato
et al., 2012; Kwon
et al., 2013 (FUS low
complexity region)).
? ? ?
TDP-43 ALS; FTD Yes (Guo et al., 2011;
Fang et al., 2014 (A315T
variant); Chen et al.,
2010; Furukawa et al.,
2011 (G294A variant))
Yes (Nonaka et al.,
2013)
Probable
(Nonaka et al.,
2013)
?
Cu/Zn
SOD
ALS Yes (DiDonato et al.,
2003(ALS-associated
mutants))
Yes (Münch et al.,
2011; Grad et al.,
2014)
Yes (Grad et al.,
2014)
Yes (Inoue et al.,
1991)
hnRNPA multiple system
proteinopathy
Yes (Kato et al., 2012;
Kim et al., 2013)
Yes (Kato et al., 2012;
Kim et al., 2013)
? ?
TIA-1 Welander distal
myopathy
Yes (Furukawa et al.,
2009; Li et al., 2014)
Yes (Li et al., 2014) ? ?
polyQ-
huntingtin
(htt)
HD Yes (Lotz et al., 2010;
Falsone et al., 2012)
?c ? No (Holmes et al.,
2013)
CPEBd - Yes (Raveendra et al.,
2013)
Yes (Si et al., 2003) ? ?
Sup35e - Yesa Yesa ? -
aprototypic representatives
b in the presence of heparin
cprion-like propagation with synthetic polyQ fibrils (Ren et al., 2009)
dfrom Aplysia californica
efrom Saccharomyces cerevisiae.
of noxious agents might originally represent a rational strategy
to relieve cells from toxicity. Such a hypothesis is supported
by studies showing that when the intracellular clearance of
aSyn is compromised, an elevated deployment of exosomes
carrying this protein as a cargo becomes observable (Alvarez-
Erviti et al., 2011; Danzer et al., 2012). With this respect,
an intact exosomal secretion pathway appears essential for
neuroprotection. Upon the manipulation of PARK9/ATP13A2, a
component of the exosome biogenesis machinery, cells can less
efficiently counteract intraneuronal aSyn toxicity. Accordingly,
surviving neurons from PD patients display increased levels of
PARK9/ATP13A2 (Kong et al., 2014), whereas affected neurons
show decreased levels (Murphy et al., 2013). In a purely
speculative way, deregulated cells that are no longer able to
efficiently handle the clearance of proteotoxic species might
pass over their own toxic burden to functioning cells for
disposal.
Interestingly, in vitro generated aSyn, tau, Abeta, PrP or
polyQ aggregates can be efficiently internalized when directly
applied to growing cells or animals, apparently without an
exosomal delivery (Horonchik et al., 2005; Ren et al., 2009;
Luk et al., 2012; Holmes et al., 2013; Iba et al., 2013; Aulic´
et al., 2014; Volpicelli-Daley et al., 2014), suggesting the
existence of additional pathways of transmission. As shown
for ALS-associated Cu/Zn-superoxide dismutase (SOD), parallel
exosome dependent and independent mechanisms have been
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postulated, whereby an active exosome-associated secretion can
be backed by a passive, carrier-free diffusion of toxic particles,
probably upon their release from necrotizing cells (Grad et al.,
2014).
Proteoglycans
A recent study identifies heparan sulphate proteoglycans (HSPGs)
as further key players of intercellular transmission (Holmes
et al., 2013; Table 1). HSPGs are a class of membrane proteins
conjugated to the heavily sulphated glycosaminoglycan (GAG)
heparan sulphate, which is a constituent of the extracellular
matrix (Xu and Esko, 2014). Although HSPGs are traditionally
coupled to cell attraction and migration, a pathologic link
with amyloid diseases has been postulated ever since the
identification of GAGs in various types of amyloid deposits
from affected brains (Snow et al., 1988, 1990; Spillantini et al.,
1999).
HSPGs are direct targets of pathologic PrP, aSyn, Abeta and
tau (Horonchik et al., 2005; Holmes et al., 2013). All of them
become actively internalized after HSPG binding, consequently
propagate within neuronal cells, and sustain the development
of a pathologic condition. The physico-chemical integrity of the
GAG-chains appears essential for binding, as the subsequent
internalization becomes affected upon chemical or genetic
alteration of the GAG residues (Holmes et al., 2013). Indeed,
GAGs were attributed amyloid modifying properties in vitro
depending on the size (Vieira et al., 2014) and charge (Lawson
et al., 2010) of the GAG chain. Given that the proteoglycan
expression and GAG-composition are cell-specific and vary with
brain development and senescence (Rykova et al., 2011), it
can be speculated that ageing-related changes in cell-surface
proteoglycan patterns will influence HSPG-mediated prion-like
propagation.
HSPGs might represent a converging hub for exosome-
dependent and independent prion propagation, owing to some
potential overlaps between both pathways. HSPGs can regulate
also exosome internalization (Christianson et al., 2013), and
GAG modifications affect both amyloid internalization and
exosomal uptake (Christianson et al., 2013; Holmes et al., 2013).
Both processes further initiate macropinocytosis, a mechanism
whereby macromolecules are taken up by actin-membrane ruffles
(Fitzner et al., 2011; Holmes et al., 2013). Finally, exosomes
and proteopathic seeds activate identical neuroinflammatory
pathways (Thellung et al., 2007; Tomasi, 2010; Christianson
et al., 2013). Collectively, these considerations suggest an
exosome/HSPG unifying route for prion entry.
AMYLOID FUNCTION
PHYSIOLOGIC SIGNIFICANCE OF AMYLOID POLYMERIZATION
While in humans the concept of amyloid has been traditionally
interpreted in terms of lethality, observations from various
evolutionary distinct organisms strongly support a role that
extends well beyond toxicity. In prokaryotes, cell-surface amyloid
polymerization is quite diffuse (Dueholm et al., 2013), and
the biogenesis of curli filaments from enterobacteria is an
example of how unicellular organisms use amyloidogenesis
for physiological processes such as biofilm formation, host
adhesion, and cellular clustering. CsgA protein, the principal
component of curli in E. coli, polymerizes into amyloids
after the secretion across the outer membrane. In vivo, this
process is strictly regulated by CsgB, an accessory protein
whose gene is localized to the same operon as the CsgA gene,
and that serves as an obligatory nucleation seed for CsgA
polymerization (Shu et al., 2012). CsgB rapidly assembles into
beta-sheet rich oligomers that massively catalyze the transition
of inherently unstructured CsgA monomers into amyloid.
Interestingly, in vitro isolated CsgA can separately polymerize
into amyloid fibrils also in the absence of CsgB. This difference
suggests that curli amyloidogenesis in living cells is under
the stringent control of a dedicated trigger which actually
restricts the assembly of amyloids to an immediate physiological
request.
In mammalian organisms, a functionally controlled amyloid
growth process has been proposed for melanosomes, a type of
organelles used for the synthesis and storage of melanin body
pigments. The transmembrane protein Pmel17 was identified as
a major component of amyloid fibers that organize in linear
arrays through the length of the organelle (Raposo et al.,
2001), and functionally serve as melanin deposits. Pmel17
is a multidomain protein that undergoes multiple sequential
posttranslatory processing and protease cleavage steps on its way
to becoming functionally incorporated into amyloid fibers on the
membrane of mature melanosomes (Leonhardt et al., 2013). One
critical point is the late cleavage and extralumenal release of the
N-terminally located regions RPT (an imperfect repeat region),
PKD (polycstic kidney disease domain), and NTR (N-terminal
region). RPT and PKD represent soluble core amyloidogenic
fragments that can assemble into fibers once cleaved, while
NTR is not amyloidogenic, and seems to serve as a specific
stabilizer of RPT and PKD during fibril growth. When this
property of NTR is impaired, the fibrillogenic fragments are
degraded and amyloid polymerization of RPT and PKD cannot
occur.
Both mechanisms described above highlight a possible
safeguard strategy by which the integrated generation of specific
amyloid promoting factors simultaneously to amyloidogenic
particles drives polymerization towards mature amyloid fibers
instead of potentially harmful misfolded intermediates. This
provides a means to exploiting stringently controlled amyloid
polymerization for functional purposes.
One further example for function-associated amyloidogenesis
comes from mammalian secretory granules of pituitary glands,
where a set of peptide hormones accumulate in form of aggregates
with amyloid properties, being reactive to amyloid-specific
immunodetection, ThioS and Congo Red staining, and with a
typical cross-beta x-ray diffraction pattern (Maji et al., 2009).
Interestingly, a variety of isolated peptide hormones is capable
of amyloid fiber formation at moderately acidic pH and in the
presence of glycosaminogylcans, two conditions similar to those
within secretory granules, while partially resolubilising when
exposed to extragranular conditions (pH 7.4). This behavior
leads to suggest that secretory granules can store hormones in
form of tightly packed amyloids, releasing monomeric hormone
units under determinate stimuli, which would obviate the
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need of a repeated de novo synthesis without affecting the
immediate availability of the substance. The further confinement
of hormone polymers within a coating membrane provides a
means for cells to store amyloid under relatively innocuous
conditions.
In spite of the strong pathologic link to disease, it appears
that under certain conditions cells are also able to exploit
the amyloid properties of prions for functional profit. Major
mechanistic insights on prion function derive from the yeast
Saccharomyces cerevisiae, an organism that ingeniously turns
conformational variability underlying prionogenesis into selective
advantage (Chernova et al., 2014). In yeast, the insurgence and
propagation of new phenotypic traits is sometimes coupled to
the ability of determinate proteins to convert from a native into
an alternative conformation with a substantially altered original
function. This type of conformational rearrangement occurs in a
fashion typical of prions, in that the prion conformer (A) displays
structural and physical features of amyloids, (B) catalyzes its
own template-driven conversion, and (C) can be non-genetically
transmitted. As prototypically shown for the yeast protein Sup35
(Tuite and Cox, 2006), a transition from a native [PSI−] into
a self-perpetuating prion conformation [PSI+] is accompanied
by a remarkable acquisition of novel cellular phenotypes, which
can be ascribed to a functional loss when soluble Sup35,
which is a release factor that controls the fidelity of ribosome
translation termination, converts into unsoluble amyloid. Under
selective pressure, the functional loss of Sup35 can turn into an
advantage, as it improves the prevalence of cryptic phenotypes
capable of coping with an altered environment (Halfmann
et al., 2012). Even more intriguing, also prokaryotes appear to
sustain prion inheritance, being able to propagate the [PSI+]
phenotype over several generations under conditions that do
not permit de novo prion formation (Yuan et al., 2014). This
finding points to prion transmission as an ancient mechanism of
inheritance.
Although such an impressive strategy shows that prions can
be tolerated in principle, bargaining of phenotypic homoeostasis
is hardly conceivable in neurons. First, the outspoken toxicity
of prions in mammalian neurons overrides any possible
adaptation to selective pressure within an evolutionary observable
time scale. Second, mammalian cells lack essential regulators
of yeast prion inheritance (e.g., the molecular chaperone
hsp104).
With this in mind, it might sound heretical to speculate
about prion-associated physiological benefits for mammalians.
However, also in higher eukaryotes, polypeptides with bona fide
prion properties exist more frequently than it might sound
reasonable for a purely toxic agent. Algorithms trained to
identify possible prion signatures could pinpoint one prevailing
structural pattern to amino acid stretches of low structural
complexity abounding in glutamine and/or asparagine residues.
The validity of these predictions could be experimentally verified
case-by-case for proteins from yeast as well as from higher
eukaryotes (Alberti et al., 2009; Toombs et al., 2010; Couthouis
et al., 2011). Interestingly, the isolated region (referred to as
prion-like region PLR) is sufficient to confer self-perpetuating
traits typical of yeast prions even when artificially fused to
unrelated proteins, when interchanged between proteins, or when
heterologuosly expressed in yeast (Sondheimer and Lindquist,
2000; Gilks et al., 2004; Li et al., 2014; Udan-Johns et al.,
2014).
Such a typically modular architecture of prion-like regions
comes along with an autonomous ability to inherently fold
into amyloid-like conformations (Kato et al., 2012). Given
that protein modules serve for a precise functional purpose, it
can be expected that amyloid folding provides more than the
structural blueprint of proteotoxicity. For the neuronal isoform
of cytoplasmic polyadenylation element-binding protein (CPEB)
from the aquatic snail Aplysia californica, the aggregation into
an active polymer is essential to regulate the simultaneous
processing of multiple RNA molecules in a spatially organized
and highly coordinated fashion (Raveendra et al., 2013).
Amyloid aggregation guides the local and reversible assembly
of CPEB monomers at the synaptic ends of neurons, where
this protein operates for long-term memory purposes. The
resulting supramolecule is functionally active, showing a much
higher RNA binding affinity than the monomeric units.
Biostructural analyses have confirmed that functional CPEB
aggregates display a typical amyloid conformation, consisting
of a high beta-sheet content and an x-ray diffraction pattern
at 4.7 and 10.7 A. Importantly, the RNA-binding domain
does not incorporate into amyloid fibers and remains solvent
exposed, substantiating the hypothesis that only the prion-like
region functions like an autonomous and specialized structural
module.
In analogy, prion-like assembly is a functional aspect
of RNA-binding protein FUS, a 53 kDa protein with an
aggregation propensity that is typically linked to the occurrence of
unsoluble protein inclusions in amyotrophic lateral clerosis (ALS)
and frontotemporal dementia (FTD; Shelkovnikova, 2013). In
fundamental contrast to such a type of irreversible aggregation,
some recent studies point to FUS self-assembly as a reversible,
regulated, and explicitly functional process. Schwartz et al.
describe one type of RNA-induced FUS polymers as characteristic
amyloid beta-zipper structures with a significantly increased
affinity for RNA polymerase II (RNAPolII) as compared
to monomeric FUS (Schwartz et al., 2013). In a separate
study, Kwon et al. suggest a biologically regulated nature
of this interaction, showing that amyloid-like hydrogels (see
Section Prion-like aggregation as an organizing principle of
intracellular granule formation) obtained from isolated FUS-
PLR bind to RNAPolII in a mode that can be reversed by
phosphorylation (Kwon et al., 2013). Further, by using a FUS-
PLR/GAL4 gene reporter construct, the authors highlight how
mutations of PLR amino acid repeats [G/S]Y[G/S], which
are critical for beta-zipper formation, compromise amyloid-
like association and transcriptional activation to the same
extent, demonstrating that FUS amyloid polymerization is tightly
coupled to function. Moreover, a recent study identifies PLR-
mediated self-assembly of FUS as an essential process for
chromatin binding and transcriptional activity (Yang et al.,
2014). Although the authors do not specify the physical
properties of the assemblies, the regulatory character of
this biochemical process and mechanistic analogies to the
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RNAPolII complex legitimate the hypothesis of an amyloid-
like polymerization. Consistent with such an assumption, the
chromatin-associated oligomerisation step requires the presence
of RNA, which might trigger amyloidogenesis as a functional
prerequisite.
PRION-LIKE AGGREGATION AS AN ORGANIZING PRINCIPLE OF
INTRACELLULAR GRANULE FORMATION
Intriguingly, both CPEB and FUS are representative RNA-binding
proteins, a category of polypeptides ranking unsuspectedly high
among predicted prion-like candidates. This finding is significant,
because proteins such as FUS are constituents of RNA granules, a
species of remarkably dynamic organelles that controls major key
steps of RNA metabolism from synthesis to splicing, processing,
stabilization and degradation (Thomas et al., 2011). While some
of them are constitutive, other can generate de novo upon
specific needs and disassemble afterwards. Such a remarkable
plasticity is favored by the lack of a confining membrane, which
allows for an uncomplicated interchange of molecules with
the intracellular environment. Underlying this dynamics is the
property of RNA-binding proteins to shuttle between separate
subcellular compartments, to repartition between various types
of RNA granules, and to dissociate from them in probable
adaptation to selective cellular demand. Systems approaches on
neuronal RNA granules suggest that these types of organelles
share only little core protein similarities, supporting the fact that
the majority of protein components associates transiently and
specific to immediate functional requirements. (Fritzsche et al.,
2013).
The frequency by which prion-like protein candidates seem to
actively influence function, size, and cell number of RNA granules
has led to the assumption that their PLRs might serve as rational
protein-protein interfaces that naturally control condensation,
growth, integrity and dynamic reorganization of these organelles
by means of amyloid polymerization. Strong support comes
from the observation that some isolated, recombinant PLRs
from RNA granule components can spontaneously condensate
in vitro into hydrogel-like particles with a fibrous morphology
and amyloid-like structural properties (Kato et al., 2012). Unlike
mature amyloid fibers from unsoluble inclusions, however,
these cell-free assemblies are relatively fragile, and reversibly
decompose into monomers already under semi-denaturing
conditions. Yet, they are sufficiently stable to in vitro emulate
morphogenesis and steady-state dynamics of RNA granules
with staggering simplicity (Han et al., 2012; Weber and
Brangwynne, 2012; Kwon et al., 2013): (A) they originate via
self-assembly either upon concentration-dependent or template-
driven nucleation, (B) they undergo demixing phase separations
typical of membrane-free organelles, (C) they are able to
heterotypically incorporate or exchange additional RNA granule-
associated protein components, (D) they tend to associate
preferentially with extended 3’-UTR mRNAs sequences, and
(E) they respond to post-translatory modifications in a way
that reflects physiologic regulation of RNA granules. These
findings highlight the potential of PLR-containing proteins to
reproduce major hallmarks of RNA granule biogenesis and
function by accessing a polymer state which is morphologically
close to amyloid, but completely reversible and therefore
devoid of any stable higher order aggregates characteristic
of pathologic prions. As these polymers unify basic physical
properties of stable amyloids (self-organization, cross-beta
structure) with reversibility and a minimal toxic hazard, they are
potentially appealing for physiological use. First, the spontaneous
polymerization of prion-like components can be initiated only
upon an incisive conformational change, e.g., by molecules
that act as nucleators. Second, polymerization comes along
with a sharp phase transition from liquid to gel-like, which
closely resembles physical processes of granule condensation
in vivo (Dundr, 2012; Weber and Brangwynne, 2012). Third,
by retaining the unique cross-beta amyloid structure, amyloid-
like polymers allow for a tight polymer stacking, which can
be useful when a locally restricted accumulation of proteins
up to very high concentrations is biologically required. Fourth,
their aggregation/deaggregation is susceptible to biochemical
stimuli such as post-translatory modifications, allowing for a
physiologically organized dynamics.
In principle, these attributes all comply with physical
prerequisites of RNA granule assembly and disassembly, such as
nucleation upon demand, steady-state association, and a precise
spatial and temporal separation, suggesting mechanistic parallels
between cell-free hydrogel aggregation and granule biogenesis
in vivo. The analysis of stress granule (SG) dynamics provides
particular support to this assumption. SG are one type of
membraneless organelles that originate transiently in the cytosol
upon different forms of cellular challenge, contributing to the
arrest of mRNA translation in response to generic insults such
as intoxication, UV-irradiation, oxidative stress and heat shock
(Kedersha et al., 2013). When homeostasis is restored, these
granules dissolve rapidly and completely.
The protein and RNA composition of SG is extremely
heterogeneous and highly variable, with a growing number of
proteins being identified as regulators. This dynamic constitution
reflects a possible ability of SG to individually respond and adapt
to various types of stimuli. Significantly, SG reversibly incorporate
proteins from multiple stress signaling pathways, therefore
becoming actively integrated into the circuitry of separate
signaling cascades. Phosphorylation of eukaryotic initiation
factor 2a (eIF2a), which represents an integrated response to
different stress stimuli and is the best investigated trigger of
SG assembly, abolishes translation initiation, causing polysome
disruption and the passing over of untranslated mRNA to
SG under persisting stress (Anderson and Kedersha, 2008).
Upon a restored homeostasis, SG rapidly dissociate, thereby
releasing bound mRNA for appropriate processing. Further SG
components point to regulation of cell death during stress. The
incorporation of the adaptor protein RACK1 into SG inhibits the
activation of MTK1, a kinase that acts upstream of the p38/JNK
apoptosis pathway (Arimoto et al., 2008). Similarly, upon binding
to SG, ROCK1, a component of Rho GTPase signaling cascades,
loses the ability to transduce apoptotic stimuli (Tsai and Wei,
2010). Finally, SG sequestration of TORC1, a component of the
Target of Rapamycin (TOR) pathway, alters metabolism during
nutrient deprivation (Wippich et al., 2013). All these effects can
be reversed upon SG dissociation, in alignment with a regulatory
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nature of these interactions, which leads to ask how the SG
proteome can adapt its composition to selected stimuli.
One possible explanation comes from the observation that
several SG-associated signaling proteins can couple SG initiation
to concomitant pathway-specific protein-protein interactions. As
shown for dual specificity tyrosine-phosphorylation-regulated
kinase 3 (DYRK3), this enzyme nucleates SG in response
to a signal-induced concentration increase via an N-terminal
low complexity region, which is concurrently required for the
sequestration and functional inactivation of TORC1 (Wippich
et al., 2013). As overexpressing the isolated N-terminal region is
sufficient to simultaneously evoke both processes, it is likely that
DYRK3 induces the condensation of granules specifically tailored
to fit TOR signaling demands.
Although it is unclear whether DYRK3-mediated SG assembly
actually involves amyloid-associated polymerization, it is
intriguing to note how the majority of established SG-nucleating
proteins have a significantly high predicted amyloidogenic
propensity (Table 2). One more explicit indication comes from
the study of the two prototypic SG nucleators TIA-1 and TIA-1
related (TIAR). Both proteins possess three distinct RNA binding
domains (RRM1-3), and under normal conditions, they absolve
splicing-associated roles in the nucleus, where TIA-1 has been
described to recognize poly-uridine sequences to facilitate 5’
splice site recognition by U1 small nuclear ribonuclein (Izquierdo
et al., 2005; Singh et al., 2011). Under stress conditions,
these proteins can sense the increase of translationally stalled
mRNA by reversibly binding to AU-rich elements in the 3’-
UTR (Kedersha et al., 2000). They subsequently move to the
cytosol and nucleate the assembly of SG, a process that requires
their intact C-terminal Q/N-rich PLR region, a low structural
complexity sequence with a high predicted prion score (Gilks
et al., 2004; Couthouis et al., 2011). Accordingly, TIA-1 is capable
of self-sustained transmission in yeast (Li et al., 2014), and
it can associate into amyloid fibrils in vitro (Furukawa et al.,
2009; Li et al., 2014). While the deletion of the PLR region
completely abolishes SG assembly, its replacement with an
extraneous PLR with similar aggregation properties (e.g., that of
yeast prion Sup35) completely restores the ability (Gilks et al.,
2004), which is a striking indication for prion-like aggregation
as an inherent mechanism of SG self-organization. In close
conjunction, aggregated TIA-1 acquires the ability of binding
stalled ribosomes, suggesting that this protein mediates the
efficient sequestration of abortive preinitiation complexes by
nucleating SG assembly (Gilks et al., 2004). These data provide
a further demonstration of how SG can be modeled in response
to specific functional purposes, further suggesting that amyloids
can serve as structural backbone and adapter modules of highly
dynamic supramolecular machines.
STRESS GRANULES MISASSEMBLY AS AN INHERENT RISK OF
FUNCTIONAL PROTEIN AGGREGATION
Intriguingly, the overexpression of an isolated TIA-1 PLR
lacking the three RNA binding domains generates deteriorated
aggregates which are no longer reversible, and refractory
to SDS denaturation and protease digestion (Gilks et al.,
2004), a pattern typical of pathogenic prions (see Section
Table 2 | Amyloidogenic propensity of SG nucleating proteins
(adapted from Kedersha et al., 2013) calculated by the PASTA
algorithm, which evaluates the stability of putative cross-beta
pairings between different amino acid stretches (Walsh et al., 2014).
Protein Lowest energy value
Ago2 −9.49
Ataxin2 −9.06
Caprin1 −6.49
CPEB −7.07
DDX3 −8.21
DYRK3 −6.77
FASTK −10.38
FMR1 −6.94
G3BP1 −6.94
MEX3B −7.44
PARP1 −6.94
PKR −6.37
PQBP1 −3.75
DAZAP2 −4.84
Pumilio −7.70
DHX36 −13.24
Roquin −10.42
SMAUG −7.25
SMN −6.67
TIA1 −6.12
TIAR −6.13
TTP −4.9
The list reports the best aggregation pairing energy values for the most
aggregation prone peptides. Values below a threshold of −5 are considered
confidential. Values of representative amyloidogenic peptides from PrP, aSyn and
Abeta are −16.04; −7.24; and −8.86, respectively.
Molecular pathways of amyloid propagation). This type of
aggregates is not functional, being unable to recruit ribosomes,
and insensitive towards conventional degradation (see Section
Molecular catchers in the amyloid rye: heat shock proteins
and proteolytic pathways), which leads to an unusual cytosolic
persistence (several days instead of a few hours) and precipitation.
This process anticipates the catastrophic consequences of an
uncontrollable and irreversible aggregation, giving an impressive
suggestion of why functional aggregation must imply reversibility.
This observation is outstanding, considering that alterations in
SG integrity, such as assembly/disassembly disequilibria or the
improper incorporation of protein components correlate to the
prevalence of organic disorders (Banfield et al., 2014). Indeed, in
the cell, many regulatory networks are composed of abundant, but
thermodynamically unstable (supersaturated) proteins, which are
primarily vulnerable to the appearance of excessively stabilized
aggregates (Ciryam et al., 2013). While soluble under homeostatic
conditions, this type of proteins can easily tilt into unsoluble
upon any unbuffered conformational perturbation (Xu et al.,
2013). Olzscha et al. have emulated in situ the effects of amyloid
overload (Olzscha et al., 2011). The exaggerated exposure of cells
to artificially superstabilised amyloid particles caused the collapse
of entire metastable protein pathways, affecting RNA metabolism,
protein turnover, and mitochondrial integrity among others. All
these activities are indeed gravely impaired in amyloid-associated
neurodegenerative disorders, and significantly, supersaturated
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proteins abound within neurodegenerative disease pathways
(Ciryam et al., 2013).
This concept can be extended to SG, as these organelles
must preserve reversibility as a prerequisite for physiological
function (Kedersha et al., 2000). Processes that modify the
assembly/disassembly, and thereby the steady-state integrity of
SG, have been associated to misfolding, mislocalisation, or
sequestration of various SG components, such as TDP-43, FUS,
and hnRNPA isoforms, which are all outstanding modifiers of
inclusion body neuropathologies (Iguchi et al., 2013; Kim et al.,
2013; Shelkovnikova, 2013). TDP-43 is a 43 kDa protein originally
identified as a transcriptional repressor of HIV-1 transactivation
response element. It is aggregation prone (Johnson et al., 2009),
and unsoluble intracellular inclusions containing this molecule
can be found in patients suffering from FTD and ALS. This
protein seems to absolve multiple RNA-devoted roles and it is
predominantly nuclear, associating preferentially with splicing
components. In the cytosol, endogenous TDP-43 interacts with
components of the translation machinery, and it incorporates
into SG upon various acute stress stimuli (arsenite intoxication,
heat shock, proteasome inhibition). Although it is not a primary
nucleator of SG, this protein influences size, morphology, and
on/off kinetics of this organelle. Cells deprived of TDP-43 or
mutations that decrease SG incorporation (R361S) lead to a
significant delay in the appearance of SG, which are smaller in size
and of less regular shape (Colombrita et al., 2009; Liu-Yesucevitz
et al., 2010; McDonald et al., 2011).
While the localization of TDP-43 to SG is reversible and
usually restricted to acute stress conditions, a forced cytosolic
permanence of TDP-43, either upon persistent stress or due
to genetic mutations, seems to potentiate the appearance
of irreversible protein aggregates (Liu-Yesucevitz et al., 2010;
Bentmann et al., 2012; Parker et al., 2012). In cells exposed
to sustained stress, TDP-43 initially localizes to SG, but finally
assembles into unsoluble cytoplasmic inclusions resistant to
SG-disrupting chemicals such as cycloheximide (Parker et al.,
2012). A similar effect was observed after the expression
of disease-associated mutants G294A, A315T, Q331K, and
Q343R (Figure 1), which all have an increased cytosolic/SG
localization pattern (Liu-Yesucevitz et al., 2010) and a major
aggregation propensity (Johnson et al., 2009; Chen et al.,
2010; Guo et al., 2011). In the presence of these mutants,
SG were more abundant upon induction, and in contrast
to wildtype-TDP-43, they partially converted into unsoluble
species. These findings suggest that under adverse conditions, the
incorporation of TDP-43 into SG can favor their conversion from
physiologically regulated reversible organelles into irreversible
cytosolic aggregates.
Similarly to TDP-43, FUS is an RNA-binding protein with
probable roles in transcriptional activation and gene splicing
(Schwartz et al., 2012, 2013; Yang et al., 2014), and consistently,
it resides predominantly in the nucleus. The association of
wildtype FUS with SG seems to be much weaker and more
stimulus selective than for TDP-43 (Acosta et al., 2014), but it
becomes generally favored upon a forced cytosolic permanence,
such as for the disease-associated variants R495X, R521C, R521L,
all impairing nuclear localization of FUS (Figure 1). These
mutants have an increased aggregation propensity, and readily
incorporate into SG upon arsenite treatment (Bosco et al., 2010;
Aulas et al., 2012; Bentmann et al., 2012; Baron et al., 2013;
Acosta et al., 2014). In analogy to TDP-43, the interaction is
still reversible, but with evident alterations in SG morphology
and dynamics, as shown by ALS-linked FUS-R945X. This NLS
lacking truncation mutant increases the number and size of
SG upon persisting stress, although initially disfavoring the
assembly of SG (Bosco et al., 2010). Intriguingly, natural or
artificial FUS mutants (e.g., R522G) fail to incorporate into SG,
accumulating as separate cytosolic inclusions with morphological
and dynamic features distinct from SG, and more reminiscent
of intracellular bodies associated to neuropatholgic disorders
(Shelkovnikova et al., 2014). In contrast to SG, this type of
FUS inclusions has a more irregular shape, a much higher
kinetic stability than SG, the ability to fuse with each other,
and it barely contains SG markers. These findings lead to
speculate that SG might transiently incorporate mislocalised and
aggregation-prone variants of FUS to prevent aggregation during
acute stress, however at the increased risk of an own overload
and subsequent precipitation when the stress stimuli become
excessive.
Mislocalisation of FUS seems to have multiple pathologic
overlaps, as its prolonged extranuclear permanence, while
affecting SG dynamics, also prevents this protein from correctly
absolving typically nuclear functions. Wildtype FUS can bind
to transcriptionally active chromatin, acting as a possible
transcriptional regulator (Yang et al., 2014). This property is
challenged when nuclear localization is impaired, as for FUS-
R495X, which is transcriptionally far less active than the wildytpe.
Moreover, mislocalised FUS is no longer able to assist the
biogenesis of gems, a class of nuclear RNA processing granules
with major roles in spliceosome organization (Yamazaki et al.,
2012), leading to a condition closely similar to the motoneuron
disorder spinal muscular atrophy (SMA). This type of disease
is otherwise linked to mutations in SMN, a protein which is
essential for the structural and functional integrity of gems
(Liu and Dreyfuss, 1996). It was shown that FUS can interact
with SMN, contributing to the regulation of homeostatic gem
assembly, a property which was no longer observable for the
R495X truncation variant. Therefore, one defect might link the
occurrence of cytoplasmic inclusions in ALS with the loss of
nuclear gems in SMA, suggesting a converging mechanism for
both diseases.
As TDP-43, FUS and hnRNPA are amyloidogenic (Table 1),
it is relevant to ask how this property might influence their
association with SG. Some more amyloidogenic protein variants
exhibit indeed a significantly enhanced tendency to incorporate
into SG (Figure 1), suggesting a causal link between both
processes. Recently discovered ALS/multisystem proteinopathy-
associated hnRNPA1 and hnRNPA2B1 variants (D262V and
D290V, respectively) show an increased tendency to form steric
zippers, the complementary beta-stranded backbone of amyloid
fibers, in concomitance to a significantly more pronounced
recruitment to SG (Kim et al., 2013; Figure 1). Moreover, the
removal of multiple tyrosine residues at different positions of
[G/S]Y[G/S] beta-zipper nucleating repeats of FUS-PLR abolishes
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FIGURE 1 | Schematic representation of PLR-containing
SG-associated proteins and of natural mutations discussed in this
review with respect to their amyloid and SG-modifying
properties. The red line marks respective prion-like regions. RRM:
RNA recognition motif; RGG: glyine/arginine rich domain; NES: nuclear
export signal; NLS: nuclear localization signal; ZnF: zinc finger domain;
Gly-rich: glycine rich region; SYQG-rich:
serine/tyrosine/glutamine/glycine rich region.
both amyloid-like hydrogel polymerization (see Section Prion-
like aggregation as an organizing principle of intracellular granule
formation) and the incorporation into SG (Kato et al., 2012). Such
an explicit relationship has not been demonstrated for TDP-43,
although two natural mutations (G294A and A315T) have been
separately described as more amyloidogenic (Chen et al., 2010;
Guo et al., 2011) and more prone to associate with SG (Liu-
Yesucevitz et al., 2010; Figure 1).
SG dynamics is also challenged by amyloidogenic proteins
without a “canonical” prion-like region, such as htt or
tau. Huntington Disease (HD) key pathogen htt displays a
highly variable polyglutamine (polyQ) sequence that develops
amyloidogenic and pathogenic properties above a threshold
length of around 40 glutamines. In a mouse model for HD,
the intracellular aggregation of a 42Q htt variant caused a
massive co-aggregation and functional inactivation of TIA-1
(Furukawa et al., 2009). This process is likely to involve cross-
nucleation, as htt-derived amyloid fibers were able to seed
for TIA-1 amyloids. Intriguingly, non-aggregating htt (25Q)
seems to physiologically associate with components of RNA
granules without compromising their activity (Savas et al.,
2010), suggesting that htt evolves from granule-stabilizing into
granule-destabilizing upon the acquisition of amyloidogenic
traits. A similar disease-linked association likely occurs for
hyperphosphorylated tau, which co-localizes with TIA-1 positive
SGs in animal disease models (Vanderweyde et al., 2012).
Interestingly, this interaction is dependent on the progression
of the disease, being weak to moderate at the beginning, and
increasing with disease severity.
Collectively, these data suggest that SG are extremely sensitive
to processes affecting their transient nature, with an excessive
stabilization leading them to evolve into irreversible toxic
aggregates comparable to those of artificially stabilized amyloids
(Olzscha et al., 2011). This might explain their rigorously time-,
space- and stimulus-confined mode of action.
THE BOUNDARIES OF TOLERATED PROTEIN AGGREGATION
The previous section has capitalized how functional aggregation
occurs incredibly close to catastrophe, and how the boundaries
between function and toxicity are startlingly fragile. This leads
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to wonder what kind of strategies cells adopt to physiologically
benefit of a process that goes hand in hand with major system
failure.
Gsponer and Babu propose that aggregation can indeed
defy proteotoxicity as long as it is controllable, reversible,
and temporally and spatially localized (Gsponer and Babu,
2012). They point to the existence of multilevel control
mechanisms by which cells manage to keep the concentration
of aggregation-prone proteins constitutively below a critical
threshold. Aggregation can then be driven by a self-organized
monomer-polymer transition following Le-Chatelier’s principle
basically by increasing protein abundance upon specific demand.
Such a mechanism would apply to explain the dynamic
consistency of SG and other transient cellular aggregates, which
might form and disrupt upon precise fluctuations of their protein
components.
In substance, the fates of aggregation-prone proteins are
governed at nucleic acid and protein level. At nucleic acid level,
a stringent control of transcripts aims at reducing the expression
of aggregation-prone proteins to an essential minimum. The
physical regulation of mRNAs encoding aggregation-prone
proteins is fundamentally different from mRNAs of non-
aggregating proteins. The former type of mRNA has a slower
transcription rate, it is preferentially escorted by regulatory RNA-
binding proteins, it has a higher tendency to form secondary
structure retarding the initiation of translation, and it has
mediocre translation efficiency due to a less optimal codon usage
and a lower ribosome density per transcript (Gsponer and Babu,
2012).
At protein level, a scrupulous surveillance of protein function
and folding quality aims at counteracting the accumulation
of misfolded and dysfunctional polypeptides (Hipp et al.,
2014). Cells are equipped with high-fidelity machineries that
systematically minimize the accumulation of misfolded proteins
by coupling protein quality control and clearance. These processes
are kept in balance by an intensive cross-talk between molecular
chaperones and different degradation machineries. Molecular
chaperones are proteins capable of discriminating native
from non-native and aggregation-prone protein conformations,
selecting irreparably misfolded polypeptides for degradation.
This decisional power is fundamental to neutralize adverse
effects of irreversibly misfolded proteins which have been rated
irrecoverable after failing chaperone quality screening. In this
case, substrates are redirected from folding to degradation.
MOLECULAR CATCHERS IN THE AMYLOID RYE: HEAT SHOCK PROTEINS
AND PROTEOLYTIC PATHWAYS
Heat shock proteins (hsps) are a class of representative and ubi-
quitously expressed, structurally unrelated molecular chaperones
which bind to unfolded or partially folded polypeptides
preventing them from aggregation. Hsps act in frequent
combination with each other, thereby providing a powerful
relay team, which is equipped with numerous accessory proteins
accounting for fine-tuning and coordination.
Two potent modifiers of amyloid fiber assembly are hsp90
and hsp70. While hsp70 family chaperones assist generic
protein folding processes (e.g., during polypeptide biosynthesis
or membrane translocation), hsp90 acts especially to stabilize
proteins in a near-native, yet unstable conformation until their
full structural maturation. The rationale behind the stabilization
of partially rather than entirely unfolded polypeptides is to
locally protect unstable or destabilized regions, e.g., during
rearrangements that functionally require the transient exposure
of hydrophobic moieties (e.g., during the activation of kinases or
steroid hormone receptors). Hsp90 thus prevents the collapse or
the aggregation of metastable regions by keeping them in a stalled
position (Eckl and Richter, 2013).
As hsp70 and hsp90 influence amyloid fiber assembly
at substoichiometric amounts, it has been proposed that a
transient interaction occurs already with low-abundance amyloid
precursors in order to repartition them from toxic into non-toxic
early during amyloidogenesis (Wacker et al., 2004; Evans et al.,
2006; Falsone et al., 2009; Daturpalli et al., 2013).
Both chaperones require ATP for functioning, and although
the sole presence of nucleotide-free hsp70 and hsp90 is sufficient
to suppress amyloid fiber growth in vitro, it is only by
consumption of ATP that these chaperones actively redirect
oligomeric intermediates “on- pathway” for amyloid assembly
(Falsone et al., 2009; Lotz et al., 2010). These findings underscore
the importance of ATPase-modulating co-factors for a controlled
processing of hazardous aggregates. Hsp70 requires a classic
cooperation with co-chaperone hsp40 to efficiently neutralize
toxic polyQ-htt in an energy-consuming fashion (Lotz et al.,
2010). The underlying mechanism is the property of hsp40
to selectively recognize a specific subset of alternatively folded
polyQ-htt aggregates originating during the initial amyloid
growth lag phase, while leaving other aggregates unaffected. The
targeted aggregates are antigenic for the conformational antibody
A11, which is selective for “off-pathway” species. These are
unable to template for fiber assembly, being most likely toxic.
Hsp40 subsequently presents them to hsp70, and the resulting
stimulation of the hsp70 ATPase leads to their active remodeling
and “on-pathway” redirection for the assembly into less toxic
mature fibers.
Several studies highlight the relationships between hsps
and amyloid diseases. The deletion of hsp70 genes exacerbates
pathogenesis of HD (Wacker et al., 2009), while the
overexpression of hsp70 can reduce amyloid-related phenotypes
(Klucken et al., 2004). Hsp90 was found in association with
polyQ-repeat expansions, showing a high affinity for polyQ-
expanded androgen receptor (AR), a pathogenic variant in spinal
and bulbar muscular atrophy (Waza et al., 2005). Binding to wild
type AR was more transient, and polyQ-AR was preferentially
degraded after disrupting this interaction.
The expression of hsp70 and hsp90 is frequently perturbed in
neurodegenerative disorders, and both proteins can be recovered
from different cytoplasmic inclusions along with other types
of chaperones (Hauser et al., 2005). This is consistent with
the observation that a persistent exposure to aggregates causes
the precipitation of major heat shock proteins, which is equal
to a complete failure of protein folding pathways (Olzscha
et al., 2011). With respect to SG, hsp90 and hsp70 supervise
physiologic assembly of these granules by physically stabilizing
separate components (Pare et al., 2009; Udan-Johns et al., 2014),
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but they are apparently unable to counteract excessive on/off
disequilibria, e.g., the accumulation of aberrantly stable TIA-1
aggregates. Unlike full-length TIA-1, fragments from the prion-
like region of TIA-1 lead to more stable intracellular aggregates
resistant to disaggregation (Gilks et al., 2004; see Section Stress
Granules misassembly as an inherent risk of functional protein
aggregation). Although the cell reacts by increasing the levels of
some endogenous hsps, it is only the artificial overexpression of
hsp70 that efficiently reverses the aggregation of TIA-1 prion-
like region. Otherwise, the endogenous increase of hsps is not
sufficient to impede the formation of intracellular inclusions
and the concomitant co-precipitation of hsps. This suggests that
chaperones can neutralize acute proteotoxic burden, but not a
chronic overload.
In this context, it was found that hsp70 is more inclined
to precipitate depending on the state of bound nucleotide
(Roodveldt et al., 2009), implying that a functioning nucleotide
turnover is essential to guarantee the stability of the cycle. This
constitutes a far-reaching challenge, as any stalling of the hsp70
cycle might come along with chaperone deprivation, leading to
a derangement of protein folding homeostasis. Generally, such a
scenario might be evoked by any form of energetic misbalance,
such as mitochondrial impairment, as frequently observed in
neurodegeneration (Pathak et al., 2013).
In close relation, pathologically stabilized amyloid species
appear to compete with physiological substrates for binding to
hsps. As shown for aSyn, stable oligomers can inhibit hsp70,
which is therefore no longer capable of functionally folding
other substrates (Hinault et al., 2010). Similarly, pathologic tau
displaces TDP-43 from cdc37, a dedicated hsp90 co-chaperone.
Under normal conditions, hsp90 binds to and stabilizes TDP-
43, and the pharmacologic inhibition of hsp90 primes TDP-
43 for degradation (Falsone et al., 2007; Zhang et al., 2010).
In cooperation, hsp90 and cdc37 regulate TDP-43 turnover
and the autophagic clearance of cleaved TDP-43 (Jinwal et al.,
2012). However, the inhibition of hsp90/cdc37 activity by
hyperphosphorylated tau leads to the cytosolic accumulation
of TDP-43 fragments, which eventually precipitate forming
inclusions typical of ALS and FTD.
Hsp70 and hsp90 are closely interlaced with protein
degradation, and both chaperones possess the ability to redirect
toxic aggregates to degradation (Hipp et al., 2014). Consistently,
degrading pathways take over misfolded polypeptides which
have been sorted for proteolytic clearance. These are essentially
the ubiquitin-proteasome system (UPS), chaperone–mediated
autophagy (CMA), and macroautophagy (MA). The UPS is
constituted of the core protease machinery called 26S proteasome,
and a series of enzyme classes controlling substrate recognition,
selection and targeting. For proteasome degradation, proteins
have to be covalently marked by ubiquitin, a protein that is
frequently found within protein inclusions (Dantuma and Bott,
2014). CMA consists in targeting polypeptides to the surface of
lysosomes for their specific translocation through the membrane
and the subsequent degradation. MA consists in the engulfment
of a selected cargo into a double-membrane vesicle, with
subsequent fusion to endosomes or directly to lysosomes. All
these degradation mechanisms are directly involved in the
clearance of amyloid aggregates at different stages. Partially
redundant overlaps between proteolytic pathways additionally
provide a compensatory advantage, since one malfunctioning
complex can be usually backed by the mutual activation of at
least another complex, keeping the toxic burden innocuously
low. Such a fail-safe strategy is very effective at intransigently
counteracting the risks arising from protein misfolding. Indeed,
the entire amyloid folding landscape is rigorously subjected to
this type of control. With functional aggregation occurring within
supervised boundaries, pathogenic drifts towards misfolding
can be timely suppressed and potentially toxic aggregates can
be delivered to the most qualified clearance system. By these
means, the cell can broadly manage the turnover of different
physical species of protein aggregates in the most convenient way
(Wang et al., 2009; Ebrahimi-Fakhari et al., 2011; Koga et al.,
2011; Scotter et al., 2014). The UPS controls the homeostatic
turnover of single monomeric proteins, whereas larger soluble
or unsoluble aggregates require bulk autophagy. Therefore,
proteins that aggregate in consequence to a single-molecule
degradation failure can be removed by autophagy depending
on size, morphology, and stability. Collectively, these systems
provide a regulatory basis for functional aggregation, as they can
reversibly shift monomer-oligomer transitions by regulating the
turnover, and therefore the effective cellular concentration of each
component. The aggregation of TDP-43, for example, can be kept
in physiologic equilibrium by the interplay of UPS and autophagy,
whereby monomeric TDP-43 can be degraded by the proteasome
and soluble oligomers become targeted by MA (Scotter et al.,
2014).
UPS degradation of soluble monomers seems to prevail under
homeostatic conditions, and consistently, amyloidogenic proteins
are substrates of various E3 ubiquitin ligases (Kumar et al., 2012).
For aSyn, the degree of ubiquitylation affects amyloid aggregation
in a way that reminds of active amyloid repartitioning preceding
proteolytic clearance (Haj-Yahya et al., 2013), with ubiquitin
chain length regulating stability, aggregation, phosphorylation,
and clearance.
While ubiquitylation usually occurs on internal lysine
residues, some disease-associated fragments from tau, aSyn,
TDP-43 and Abeta can also undergo an unusual N-terminal
ubiquitylation (Brower et al., 2013). This form of modification,
known as N-end rule pathway, consists of polyubiquitylation
of N-terminal arginine residues by specific E3 ligases called
N-recognins. Upon their conjugation, each of these fragments
undergoes rapid proteasomal degradation, which impedes
an excessive accumulation of these highly aggregation-prone
and proteopathic species. For Abeta fragments, an additional
N-terminal argininylation configures these peptides for the
subsequent ubiquitin conjugation step.
These findings highlight the predominant role of ubiquitin-
mediated degradation in neuroprotection. Proteasome
dysfunction seems central to neurodegeneration, and rather
generic impairments of the UPS, whether pharmacologic,
genetic, or physiologic, are sufficient for the unbiased appearance
of diverse neurodegenerative phenotypes. The chemical UPS
inhibition of dopaminergic cells favors the accumulation of
Lewy-body like inclusions (Rideout et al., 2001). Likewise, the
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stereotactic injection of proteasome inhibitors into mice brains
causes symptoms closely related to PD, including dopaminergic
neuronal death, decreased motor activities, and the accumulation
of inclusions positive to aSyn and ubiquitin (Xie et al., 2010).
Moreover, the deletion of single proteasomal (but not autophagic)
subunits is sufficient to evoke ALS symptoms in knock-out mice,
leading to mislocalisation and precipitation of TDP-43 and FUS
in motor neurons (Tashiro et al., 2012).
The integrity of the proteasome can be further challenged
by an uncontrolled overload of amyloid aggregates. For Abeta,
it was shown that aggregates can overturn the function of
the UPS by physically interacting with proteasome subunits.
Zhao and Yang suggest that a decreased proteasome activity
is not due to inhibition, but rather to the competition of
natural proteasome substrates with increasing concentrations
of amyloid aggregates, as shown for Abeta peptide (Zhao and
Yang, 2010). Similarly, the intracellular accumulation of TDP-43
or aSyn aggregates comes along with massive UPS dysfunction
(Nonaka et al., 2013; Tanik et al., 2013). These considerations
underscore the importance of a compensatory cross-talk between
each single proteolytic pathway, whereby stimulating one separate
degradation machinery can efficiently rescue malfunctions of
the other pathways (Xilouri et al., 2013). By these means,
aggregates that become renitent to conventional disposal can
be passed over for alternative clearance. aSyn, which is usually
cleared by the UPS under normal conditions, can be passed
over to MA during particular cellular challenges (Ebrahimi-
Fakhari et al., 2011). In HD, a failed segregation of cytosolic
cargo correlates with a marked increase of CMA components
(Koga et al., 2011). An effect in the opposite direction is
observed for disease-linked tau fragments, as the failure to process
them via CMA leads to the activation of MA (Wang et al.,
2009).
While the folding/degradation machineries presented above
represent major aggregate modifying pathways, the recent
discovery of the protein class MOAG-4/SERF suggests also the
existence of more selective cellular mechanisms. MOAG-4/SERF
possesses the unique ability to distinguish between amyloid and
non-amyloid/amorphous aggregation, acting as a potent amyloid
promoting factor (Falsone et al., 2012). One possible mechanistic
interpretation of this property comes from the observation
that the human homologue SERF1 binds to the C-terminal
region of aSyn, which usually shields the central amyloidogenic
region of this protein (Dedmon et al., 2005). The exposure
of amyloidogenic core regions would thereby facilitate amyloid
self-assembly. Intriguingly, the absence/presence of MOAG/SERF
has pronounced effects on the proteotoxicity of intracellular
htt, Abeta and aSyn aggregates in different model organisms.
In C. elegans, aggregation and toxicity of polyQ expansions
change in relation to the ageing-dependent expression levels of
the orthologue MOAG-4 (van Ham et al., 2010). Silencing of
MOAG-4 leads to a suppression of polyQ aggregation and toxicity,
while the overexpression significantly aggravates toxicity, shifting
polyQ towards compact misfolding intermediates. This effect is
independent of conventional amyloid modifying pathways, as it is
not influenced by alterations of the heat shock response, the UPS,
or autophagy.
At this time, a more defined functional classification of
MOAG/SERF is precluded by to the lack of detailed functional
data. Of note, human homologues SERF1 and SERF2 share
low-level homology with the RNA-binding domain of Matrin3
(Scharf et al., 1998) a protein that colocalises with small nuclear
ribonucleoproteins (snRNPs), interacts with TDP-43, and has
been recently identified as a novel disease marker for some rare
forms of ALS (Johnson et al., 2014). This might suggest a possible
role in RNA-associated (pathologic) processes.
CONCLUDING REMARKS
The purely pathological significance of amyloid protein
aggregation has been questioned by the discovery of physiological
processes that exploit some aspects of amyloid polymerization
apparently for functional purposes. The structural and
mechanistic similarity between pathologic and functional
particles, however, anticipates that benefits of amyloid
aggregation go hand in hand with toxicity. Despite these
imminent hazards, the cell seems to tolerate aggregation as long
as strictly confined within spatially and temporally delimited
boundaries, as defined by inherently low transcription and
translation rates, localized changes in protein levels, and a
high protein quality control and turnover. By these means,
aggregation-prone polypeptides are subjected to an exceptional
physical and biological supervision at almost every level of
cellular life. Yet, surveillance systems can fail upon chronic
exposure to abnormally resistant aggregates, and in spite of
some considerable functional backup, multiple simultaneous
dysfunctions can tilt the equilibrium from functional into
toxic. It is therefore conceivable, that amyloid polymerization
is physiological, as long as the cell is capable of buffering any
inherent toxicity. The occurrence of multiple system failures, as
for example during cell senescence or upon extraordinary cellular
challenges, might lead to the prevalence of toxic phenotypes,
reflecting the multifactorial nature of the associated clinical
conditions.
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